Clinical Trial Update: Effectiveness of Rituximab in Pediatric OMS Patients. [Phase 1, Phase 2]

View source ↗

Summary

The clinical trial update reports on the effectiveness of rituximab in pediatric opsoclonus-myoclonus syndrome during Phase 1 and Phase 2. The study status is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opsoclonus Myoclonus Syndrome

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: National Pediatric Neuroinflammation Organization, Inc. | Conditions: Opsoclonus-myoclonus Syndrome, Opsoclonus | Phase 1, Phase 2 | Status: COMPLETED